Institutional Ownership
Ligand Pharmaceuticals Inc
CUSIP 53220K504COM NEWLGNDQ1 2026
13D / 13G Filings
50
Schedule 13D/13G on record
Beneficial Filers
12
Distinct reporting persons
Largest Stake
17.0%
Max % of class reported
Institutional Holders
346
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
50 filings · latest Nov 14, 2025
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Nov 14, 2025 | Janus Henderson Group PLC | 13G/A | 5.3% | 1.04M | SEC |
| 2 | Oct 17, 2025 | Blackrock, Inc. | 13G/A | 14.5% | 2.84M | SEC |
| 3 | Aug 14, 2025 | Janus Henderson Group PLC | 13G/A | 5.5% | 1.06M | SEC |
| 4 | May 14, 2025 | Janus Henderson Group PLC | 13G/A | 5.3% | 1.03M | SEC |
| 5 | Feb 14, 2025 | Janus Henderson Group PLC | 13G/A | 5.4% | 1.02M | SEC |
| 6 | Feb 5, 2025 | Blackrock, Inc. | 13G/A | 15.6% | 2.95M | SEC |
| 7 | Nov 14, 2024 | Janus Henderson Group PLC | 13G/A | 5.5% | 1.01M | SEC |
| 8 | Nov 8, 2024 | Goldman Sachs Group Inc | 13G/A | 0.3% | 52.4K | SEC |
| 9 | Nov 1, 2024 | Macquarie Group Ltd | 13G/A | 4.9% | 887.3K | SEC |
| 10 | Feb 14, 2024 | Macquarie Group Ltd | 13G | 5.7% | 987.2K | SEC |
40 more beneficial-ownership filings on Premium
See the full Schedule 13D/13G history for Ligand Pharmaceuticals Inc.
Unlock full historyTop Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Blackrock, Inc. | 2.96M | $591.35M |
| 2 | Janus Henderson Group PLC | 1.01M | $201.62M |
| 3 | Invesco Ltd. | 823.6K | $164.43M |
| 4 | State Street Corp | 778.9K | $155.50M |
| 5 | Fmr LLC | 596.1K | $119.02M |
| 6 | Nomura Asset Management International Inc. | 573.3K | $114.46M |
| 7 | Franklin Resources Inc | 573.2K | $114.43M |
| 8 | Chicago Capital, LLC | 561.7K | $112.14M |
| 9 | Geode Capital Management, LLC | 558.9K | $111.61M |
| 10 | Congress Asset Management Co | 504.6K | $100.75M |